Whole‐Exome Sequencing for Diagnostic Investigation of 267 Patients From the Brazilian Public Health System ( SUS ) Followed by Reanalysis of Nondiagnostic Cases
Clinical Genetics · 20.11.2026
DOI: 10.1111/cge.70281 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, online erschienen am 20.11.2026. Verfasst von Bruno De Oliveira Stephan und 11 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Although advances in genetic testing in recent years have improved patient care, especially regarding rare diseases, the path to molecular diagnosis remains lengthy for many patients in Brazil, particularly among families who rely exclusively on the public health system. Between 2017 and 2023, a total of 267 patients with suspected rare diseases were recruited from the Genetics Unit of the Instituto da Criança do Hospital das Clínicas da Universidade de São Paulo; blood samples from the probands and, when available, their parents were sent to Yokohama City University and submitted to whole‐exome sequencing (WES). Among the 267 cases, 124 (46.4%) received molecular diagnostic findings; most of these patients had intellectual disability or developmental delay. In addition, 130 cases (48.6%) were classified as “no relevant variant identified” and another 13 cases (4.8%) were considered inconclusive; all underwent reanalysis of WES data, which led to a molecular diagnosis in 10 additional cases (7%) previously undetected, primarily through newly established gene–disease associations or updated interpretations of previously identified variants. Our diagnostic yield (46.4%) was consistent with those reported in large cohorts and meta‐analysis published internationally. However, nondiagnostic results warrant further consideration and WES reanalysis should be considered as a strategy to improve diagnostic outcomes, even if mostly through periodic literature reviews and variant reinterpretation.
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Japan Agency for Medical Research and Development
Zitieren
APA
Stephan, B. D. O., Castro, M. A. A., Val, V. P. D., Leão, J. D., Pegos, D. S. S., Brandão, C. P., Quaio, C. R., Honjo, R. S., Bertola, D. R., Koshimizu, E., Matsumoto, N., & Kim, C. A. (2026). Whole‐Exome Sequencing for Diagnostic Investigation of 267 Patients From the Brazilian Public Health System ( SUS ) Followed by Reanalysis of Nondiagnostic Cases. Clinical Genetics. https://doi.org/10.1111/cge.70281
Vancouver
Stephan BDO, Castro MAA, Val VPD, Leão JD, Pegos DSS, Brandão CP, et al. Whole‐Exome Sequencing for Diagnostic Investigation of 267 Patients From the Brazilian Public Health System ( SUS ) Followed by Reanalysis of Nondiagnostic Cases. Clinical Genetics. 2026. doi:10.1111/cge.70281
BibTeX
@article{Stephan2026,
author = {Stephan, Bruno De Oliveira and Castro, Matheus Augusto Araújo and Val, Vitória Pelegrino Do and Leão, Juliana Duque and Pegos, Débora Sotyrios Souza and Brandão, Caroline Piai and Quaio, Caio Robledo and Honjo, Rachel Sayuri and Bertola, Débora Romeo and Koshimizu, Eriko and Matsumoto, Naomichi and Kim, Chong Ae},
title = {Whole‐Exome Sequencing for Diagnostic Investigation of 267 Patients From the Brazilian Public Health System ( SUS ) Followed by Reanalysis of Nondiagnostic Cases},
journal = {Clinical Genetics},
year = {2026},
doi = {10.1111/cge.70281}
}
EUVIMED